Simon, D., Tascilar, K., Krönke, G., Kleyer, A., Zaiss, M. M., Heppt, F., . . . Schett, G. (2020). Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nature Portfolio.
Style de citation Chicago (17e éd.)Simon, David, et al. Patients with Immune-mediated Inflammatory Diseases Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Seroconversion. Nature Portfolio, 2020.
Style de citation MLA (8e éd.)Simon, David, et al. Patients with Immune-mediated Inflammatory Diseases Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Seroconversion. Nature Portfolio, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.